Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 16,650 shares at $1.75 ($29,138)
  2. 4 Open-market sale Chief R&D Officer sold 7,355 shares at $1.75 ($12,871)
  3. 4 Open-market sale Chief Legal Officer sold 6,260 shares at $1.75 ($10,955)
  4. 4 Open-market sale 10% owner sold 56,000 shares at $1.78 ($99,630)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Chief R&D Officer sold 9,014 shares at $0.68 ($6,130)
  7. 4 Open-market sale Chief Legal Officer sold 7,606 shares at $0.68 ($5,172)
  8. 4 Open-market sale President & CEO sold 20,033 shares at $0.68 ($13,622)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Chief R&D Officer sold 9,646 shares at $0.49 ($4,727)
  13. 4 Open-market sale Chief Legal Officer sold 7,179 shares at $0.49 ($3,518)
  14. 4 Open-market sale President & CEO sold 19,877 shares at $0.49 ($9,740)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Director sold 4,359 shares at $0.69 ($3,008)
  18. 4 Planned sale Director sold 10,200 shares at $0.67 ($6,834)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Director sold 4,359 shares at $0.69 ($3,008)

Page 4 of 49 · 968 filings